Fortis Healthcare Limited — Important, 27-12-2024: General Updates

In a recent board meeting, Fortis Healthcare Limited has confirmed the appointment of Mr. Leo Puri as the Chairman of the Board, also serving as an Additional Independent Director. His term as an Independent Director spans five years, subject to shareholder approval. Mr. Puri brings over four decades of extensive experience in the financial sector, having held senior positions at JP Morgan Chase, McKinsey & Company, and UTI Asset Management Company. He has a strong history of guiding high-impact organizations, currently serving on several prominent boards including Tata Sons and Hindustan Unilever.

This leadership transition follows Mr. Indrajit Banerjee's tenure as interim Chairman starting October 1, 2024. Mr. Puri's role is expected to influence Fortis Healthcare's strategic direction, focusing on growth and innovation in the healthcare sector. The company's diverse operations include 28 healthcare facilities and numerous diagnostics labs, underpinning a strong position in India's healthcare landscape. Investors should watch closely as Mr. Puri's expertise could unlock new growth avenues for Fortis.